SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001571049-17-001927
Filing Date
2017-03-02
Accepted
2017-03-01 17:44:40
Documents
6
Group Members
CENTRIC CAPITAL VENTURES LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D t1700588_sc13da.htm SC 13D/A 58067
2 EXHIBIT 99.1 t1700588_ex99-1.htm EX-99.1 245586
3 EXHIBIT 99.2 t1700588_ex99-2.htm EX-99.2 98101
4 EXHIBIT 99.3 t1700588_ex99-3.htm EX-99.3 83590
5 EXHIBIT99.4 t1700588_ex99-4.htm EX-99.4 120040
6 EXHIBIT 99.5 t1700588_ex99-5.htm EX-99.5 4552
  Complete submission text file 0001571049-17-001927.txt   611369
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Subject) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79412 | Film No.: 17656025
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE FLOOR 18 NEW YORK NY 10022
Business Address
Sacks Bradley J. (Filed by) CIK: 0001638123 (see all company filings)

Type: SC 13D/A